Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Nov 4, 2021 · 10-Q · 35 days after period end · 0001213900-21-056770
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Net Income | -$10.78M | -$7.97M | -$1.54M | -$4.51M |
| EPS Diluted | -$0.96 | -$1.26 | -$0.92 | -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 4, 2021 · 35 d after period end
